Innoviva, Inc. Uncategorized Contracts & Agreements
33 Contracts & Agreements
- Offer Letter between Innoviva, Inc. and Stephen Basso, dated July 28, 2023 (Filed With SEC on August 25, 2023)
- Support Agreement, dated July 10, 2022, by and among Innoviva, Inc., Innoviva Acquisition Sub, Inc., Tang Capital Partners, LP and the Kevin C. Tang Foundation (Filed With SEC on July 11, 2022)
- Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated April 29, 2022 (Filed With SEC on May 2, 2022)
- Form of Capped Call Confirmation (Filed With SEC on March 8, 2022)
- ISP FUND LP c/o Sarissa Capital Fund GP LP 660 Steamboat Road, 3rd Floor Greenwich, Connecticut 06830 (Filed With SEC on May 20, 2021)
- Offer Letter between Innoviva, Inc. and Pavel Raifeld, dated May 20, 2020 (Filed With SEC on May 26, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 19, 2020)
- Agreement between Innoviva, Inc. and Marianne Zhen dated as of September 7, 2018 (Filed With SEC on September 11, 2018)
- Offer Letter with Geoffrey Hulme dated as of May 18, 2018 (Filed With SEC on July 26, 2018)
- Agreement, dated as of February 12, 2018, by and among Innoviva, Inc., Sarissa Capital Domestic Fund LP, and certain of its affiliates (Filed With SEC on February 13, 2018)
- Agreement between Innoviva, Inc. and Eric dEsparbes dated as of February 7, 2018 (Filed With SEC on February 7, 2018)
- Relocation Assistance For Michael E. Faerm (Filed With SEC on February 24, 2016)
- Relocation Assistance For Eric dEsparbes (Filed With SEC on February 27, 2015)
- EXHIBIT A Adjustments to Your Theravance Equity Awards in Connection with the Spin-Off (Filed With SEC on August 7, 2014)
- EMPLOYEE MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 1, 2014 (Filed With SEC on June 5, 2014)
- TAX MATTERS AGREEMENT by and between THERAVANCE, INC. and THERAVANCE BIOPHARMA, INC. Dated as of June 2, 2014 (Filed With SEC on June 5, 2014)
- ANNEX A RULES OF CONSTRUCTION AND DEFINED TERMS (Filed With SEC on April 21, 2014)
- ACCOUNT CONTROL AGREEMENT (Filed With SEC on April 21, 2014)
- THERAVANCE STRATEGIC ALLIANCE AGREEMENT AMENDMENT (Filed With SEC on March 6, 2014)
- MASTER AGREEMENT (Filed With SEC on March 6, 2014)
- COMMERCIALIZATION AGREEMENT by and between THERAVANCE, INC. and CLINIGEN GROUP PLC Dated: March 8, 2013 (Filed With SEC on May 1, 2013)
- THERAVANCE, INC. December , 2010 (Filed With SEC on February 28, 2011)
- Theravance, Inc. CashBonus Program, amended effective as of February 10, 2010 (Filed With SEC on February 26, 2010)
- THERAVANCE, INC. 2008 NEW EMPLOYEE EQUITYINCENTIVE PLAN (AS ADOPTED EFFECTIVEJANUARY 29, 2008) (AS AMENDED JULY 21, 2009) (Filed With SEC on August 5, 2009)
- CONSULTINGAGREEMENT (Filed With SEC on December 11, 2008)
- AMENDMENT TO AMENDED AND RESTATED RIGHTS AGREEMENT (Filed With SEC on November 25, 2008)
- CONSULTINGAGREEMENT (Filed With SEC on June 19, 2008)
- FIRSTADDENDUM TO THE TERMS & CONDITIONS DATED FEBRUARY 17, 2004 THERAVANCE, INC. AND BEN VENUELABORATORIES, INC. (Filed With SEC on November 7, 2007)
- THERAVANCE, INC. 2004 EQUITYINCENTIVE PLAN NOTICE OFSTOCK OPTION GRANT (Filed With SEC on August 8, 2007)
- Theravance,Inc. CashBonus Program, amended effective as of February 28, 2007 (Filed With SEC on March 1, 2007)
- SHARES (Filed With SEC on March 1, 2007)
- AMENDMENT TO LICENSE,DEVELOPMENT AND COMMERCIALIZATIONAGREEMENT (Filed With SEC on November 6, 2006)
- CONSULTINGAGREEMENT (Filed With SEC on August 12, 2005)
